John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 58,650 shares at $32.55 ($1.9M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($1.9M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.55 | 29,325 | $955K | 50.0% |
| 2 | $32.55 | 29,325 | $955K | 50.0% |
| Total | $32.55 avg | 58,650 | $1.9M | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |
| KNSA | SELL | 2024-09-04 | $3.1M | — | Filing → |